We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYPS icon
3201
PLAYSTUDIOS Inc
MYPS
$72.1M
$43.7K ﹤0.01%
21,110
+20,300
+2,506% +$47.8K
GCMG icon
3202
GCM Grosvenor
GCMG
$841M
$43.7K ﹤0.01%
4,475
+4,301
+2,472% +$41.5K
YSG
3203
Yatsen Holding
YSG
$315M
$43.7K ﹤0.01%
16,412
+7,357
+81% +$26.3K
FLL icon
3204
Full House Resorts
FLL
$83.5M
$43.6K ﹤0.01%
+8,728
New +$44.3K
EXFY icon
3205
Expensify
EXFY
$202M
$43.6K ﹤0.01%
29,277
+27,475
+1,525% +$43.3K
PAAS icon
3206
Pan American Silver
PAAS
$22.1B
$43.5K ﹤0.01%
2,190
-475
-18% -$9.36K
EZPW icon
3207
Ezcorp Inc
EZPW
$1.78B
$43.5K ﹤0.01%
4,155
+1,132
+37% +$11.9K
KALV
3208
DELISTED
KalVista Pharmaceuticals
KALV
$43.5K ﹤0.01%
3,691
+3,525
+2,123% +$41.1K
IPSC icon
3209
Century Therapeutics
IPSC
$353M
$43.4K ﹤0.01%
17,032
+12,676
+291% +$40.1K
ZVRA icon
3210
Zevra Therapeutics
ZVRA
$679M
$43.4K ﹤0.01%
8,856
+8,585
+3,168% +$40.7K
PBR icon
3211
Petrobras
PBR
$114B
$43.4K ﹤0.01%
2,994
-60,916
-95% -$948K
AIA icon
3212
iShares Asia 50 ETF
AIA
$5.04B
$43.3K ﹤0.01%
645
-4,817
-88% -$309K
AEHR icon
3213
Aehr Test Systems
AEHR
$4.22B
$43.3K ﹤0.01%
3,875
+3,313
+590% +$38.6K
SSP icon
3214
E.W. Scripps
SSP
$314M
$43.3K ﹤0.01%
13,780
+9,272
+206% +$29.4K
MPB icon
3215
Mid Penn Bancorp
MPB
$969M
$43K ﹤0.01%
1,959
+574
+41% +$11.9K
ACET icon
3216
Adicet Bio
ACET
$77.3M
$42.9K ﹤0.01%
2,215
+2,031
+1,104% +$54.4K
CMCL icon
3217
Caledonia Mining Corp
CMCL
$441M
$42.8K ﹤0.01%
4,400
+2,537
+136% +$26.1K
IYJ icon
3218
iShares US Industrials ETF
IYJ
$1.96B
$42.8K ﹤0.01%
358
+302
+539% +$36.8K
EWN icon
3219
iShares MSCI Netherlands ETF
EWN
$727M
$42.7K ﹤0.01%
+851
New +$42.6K
ATYR
3220
aTyr Pharma
ATYR
$53M
$42.6K ﹤0.01%
27,338
+21,071
+336% +$36.7K
HFFG icon
3221
HF Foods Group
HFFG
$99.2M
$42.6K ﹤0.01%
14,209
+10,343
+268% +$32.9K
PAMT
3222
PAMT Corp
PAMT
$279M
$42.5K ﹤0.01%
2,448
+2,140
+695% +$34.5K
PBPB
3223
DELISTED
Potbelly
PBPB
$42.4K ﹤0.01%
5,286
+4,129
+357% +$38.2K
PPC icon
3224
Pilgrim's Pride
PPC
$6.4B
$42.4K ﹤0.01%
1,102
-937
-46% -$33.8K
BNKK
3225
Bonk Inc
BNKK
$7.77M
$42.4K ﹤0.01%
1,043
+1,014
+3,497% +$53.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.